Janux Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $380.4M
Liabilities Breakdown FY2023
Total Liabilities: $36.1M
Asset Breakdown
Total Assets: $380.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $19.2M | 5.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $7.0M | 1.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $354.2M | 93.1% |
Liabilities Breakdown
Total Liabilities: $36.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.4M | 6.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $33.6M | 93.3% |